1264P Early circulating tumour DNA (ctDNA) dynamics for predicting and monitoring response to immunotherapy (IO) vs chemotherapy (CT) in patients with 1L metastatic (m) NSCLC: Analyses from the phase III MYSTIC trial

Peters, S., Rizvi, N. A., Kuziora, M., Lai, Z., Shrestha, Y., Dey, A., Barrett, J. C., Scheuring, U., Poole, L., Abbosh, C., Raja, R., & Hellmann, M. D. (2021). 1264P Early circulating tumour DNA (ctDNA) dynamics for predicting and monitoring response to immunotherapy (IO) vs chemotherapy (CT) in patients with 1L metastatic (m) NSCLC: Analyses from the phase III MYSTIC trial. Annals of Oncology, 32, S989–S990. https://doi.org/10.1016/j.annonc.2021.08.1866
Authors:
Solange Peters
Naiyer A. Rizvi
Michael Kuziora
Zhongwu Lai
Yashaswi Shrestha
Agnish Dey
J. C. Barrett
Urban Scheuring
L. Poole
Christopher Abbosh
Rajiv Raja
Matthew D. Hellmann
Affiliated Authors:
Naiyer A. Rizvi
Columbia Affiliation:
Subjects:
Genomic Landscape of Cancer and Mutational Signatures (OpenAlex Topic)
Nanotechnology and Imaging for Cancer Therapy and Diagnosis (OpenAlex Topic)
Sarcoma Research and Treatment (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/j.annonc.2021.08.1866
DOI:
10.1016/j.annonc.2021.08.1866
Journal:
Annals of Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: